Cutaneous leukocytoclastic vasculitis associated with verapamil and atorvastatin: A case report

Yi Tong Vincent Aw; Jonathan Thomas McGuane

doi:10.1002/ccr3.7683

Cutaneous leukocytoclastic vasculitis associated with verapamil and atorvastatin: A case report

Clin Case Rep. 2023 Jul 17;11(7):e7683. doi: 10.1002/ccr3.7683. eCollection 2023 Jul.

Authors

Yi Tong Vincent Aw^{1

2}, Jonathan Thomas McGuane^{2

3}

Affiliations

¹ General Medicine Department, Canberra Hospital Canberra Health Services Canberra Australia.
² Australian National University Medical School Australian National University Canberra Australia.
³ ACT Pathology, Canberra Hospital Canberra Health Services Canberra Australia.

Abstract

We report a case of biopsy-proven cutaneous leukocytoclastic vasculitis developing 10 days after starting verapamil and atorvastatin in a patient with long-standing Sjogren's syndrome. This highlights the need to monitor for this rare adverse effect.

Keywords: Sjogren's; atorvastatin; cryoglobulinemia; leukocytoclastic; vasculitis; verapamil.

Publication types

Case Reports